Biogen, Datadog, Tesla among companies with revised analyst ratings and targets
BIIB•Wall Street analysts revised ratings and price targets on U.S.-listed companies, including Biogen, Datadog and Tesla. JPMorgan raised Biogen to overweight from neutral and its target to $300 from $210; Jefferies raised Datadog’s target to $300 from $260 and Tesla’s to $400 from $350.
1. Highlighted analyst actions
JPMorgan raised its rating on Biogen to overweight from neutral and lifted its price target to $300 from $210. Jefferies raised its target price on Datadog to $300 from $260 and on Tesla to $400 from $350.
2. Broad research roundup
The roundup listed analyst rating and target-price changes for numerous U.S.-listed companies. Other highlighted target increases included Marathon Petroleum to $433 from $413 and Phillips 66 to $276 from $242, both by Jefferies.
